Logan Lutton

In an interview, Timothy Law, DO, MBA, chief medical officer of Highmark, talks about how GLP-1 agonist drugs like Wegovy and Zepbound are changing the paradigm for weight loss.

In an interview, Timothy Law, DO, MBA, chief medical officer of Highmark, talks about the issues insurers consider when providing coverage for GLP-1 drugs like Wegovy and Zepbound that can help patients lose weight.

Study results may change the understanding and treatment of hormone-based treatment of primary ovarian insufficiency based on genetics.

Elafibranor is the first new medicine approved for primary biliary cholangitis in nearly a decade.

Rytelo is the first and only telomerase inhibitor approved by the FDA and is expected to be available by the end of summer 2024.

Fears also extend to the future of Social Security, which may run out by 2036, according to the Social Security Office of Retirement and Disability Policy.

Three-quarters of disenrollments were due to procedural reasons such as incomplete applications, application errors and inaccurate contact information.

This is the first new recommendation from the American Academy of Pediatrics since the AIDS epidemic began in the 1980s.

Healthcare providers and community leaders won’t need a green thumb to implement these changes.

More than 25% of low-income families' earnings go toward healthcare costs.

Wrong diagnoses were also made in women with dense, fatty breasts.

HPV vaccine uptake increased almost 20% under guidance from the clinic-based program.

Discrimination, fear and lack of knowledge are just a few of the obstacles they face when trying to access healthcare.

Breast cancer stats from the American Association for Cancer Research 2024 Cancer Disparities Report.

The update was prompted by a recent increase in breast cancer cases among women in their 40s.

The efforts to prevent one disease increased another, likely due to the lack of methadone and sterile needles.

Persisting stigma and COVID loneliness are partly to blame.

This marks the first documented HIV transmission through cosmetic services using needles.

Cost and lack of access were two of the most common reasons given in new survey.

Lack of health insurance and not having a healthcare provider are two of the biggest factors that contribute to skipping a mammogram.

Judith Currier, M.D., M.Sc., ACTG Chair, discussed the trial, how it’s different than previous research and the connotations surrounding the “cure” to HIV.

Gregory P. Brown, J.D., partner at Hill Ward Henderson, a law firm based in Tampa, talked about potential upcoming complications for healthcare employers and employees.

Breast cancer predictions for this year.

Genes may help identify which cases of ductal carcinoma in situ are most likely to become invasive breast cancer.

Psychiatrists and psychologists also had lower in-network reimbursement rates.

Factors preventing biosimilar access include pharmacy benefit manager contracts and pharmacies not communicating with providers, a survey finds.

The Access to Prescription Digital Therapeutics Act remains a top priority for the Academy of Managed Care Pharmacy (AMCP), according to Jennifer L. Mathieu, AMCP senior vice president of professional and government affairs.

The average American can afford a maximum of a $97 for out-of-pocket healthcare expenses.

Although newly acquired HIV infection rates are low among people who are incarcerated, 95% of at-risk inmates may engage in unsafe behavior after their release, a study shows.

How COVID-19 became a jumping off point for HIV vaccine conspiracies.